NY-DNB//BACK-BAY
29.4.2024 18:01:28 CEST | Business Wire | Press release
DNB Markets (“DNB”) and Back Bay Life Science Advisors (“Back Bay"), acting through the DNB//Back Bay Healthcare Partnership are pleased to announce the dates for our highly anticipated 9th annual Nordic-American Healthcare Conference (NAHC).
Hosted by DNB//Back Bay with Nasdaq Nordic, Innovation Norway and Business Sweden, this pre-eminent US-based Nordic healthcare equity investor event will convene in New York City on March 26–27, 2025, bringing together industry leaders, investors and innovators from across the global healthcare sector.
Renowned for their excellence in life science development and commercial leadership, the Nordic markets offer a wealth of cutting-edge technologies that are shaping the future of global healthcare. Showcasing this dynamism, NAHC 2025 will offer focused tracks and panel discussions supported by DNB Markets’ recognized research analysts exploring specific industry developments that also reflect prominent capabilities in the Nordic region. NAHC 2025 will spotlight four key therapeutic and technology areas: rare diseases, metabolic disorders, oncology and med-healthtech. Approximately 30 carefully curated presenting companies, predominantly mid- and large cap public companies along with select pre-public private companies from the Nordics and the United States, will take the stage to share their insights and strategies. Over the course of two days, attendees will have the opportunity to engage with these leading Nordic companies together with US companies developing and commercializing adjacent and complementary technologies.
Attendance at the conference is by invitation only through DNB//Back Bay. Qualified investors and senior healthcare executives are encouraged to request a seat for this exclusive event, which will offer unparalleled networking opportunities along with panels and presentations exploring meaningful insights into the latest developments shaping the healthcare sector.
For more information and to request a seat at the Nordic-American Healthcare Conference 2025, please visit www.nordic-americanlifescience.com.
About the DNB//Back Bay Healthcare Partnership
DNB//Back Bay (“The Partnership”) provides healthcare companies with strategic and M&A advisory services, licensing and partnering support and execution services, a complete range of corporate and investment banking products and services, and full-scale origination and distribution capabilities in global capital markets. Together, DNB and Back Bay Life Science Advisors hold a unique position bridging the Nordic and US markets, offering support to companies along the full continuum of life science and healthcare.
Learn more here:
www.bblsa.com/dnb-back-bay-partnership
www.dnb.no/en/business/industry-expertise/healthcare/dnb-back-bay
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240429391516/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bridger Photonics Posts Record Year as Operators Turn to Trusted Emissions Intelligence4.2.2026 13:20:00 CET | Press release
Bridger Photonics (“Bridger”) closed its strongest year in company history last year, marked by record asset coverage, record revenue, and global adoption of its methane emissions data and intelligence across multiple continents and the entire oil and natural gas value chain. Bridger’s momentum reflects a clear shift in how operators choose to manage emissions: away from legacy and weather-limited approaches and toward entire asset coverage with data they can trust. Bridger continues to lead the methane detection space—growing existing customers and attracting new ones. Bridger has competitively displaced 32 customers from other aerial technologies, driven by deep industry expertise, proven data reliability and actionability, the ability to operate across challenging conditions and seasons, close coordination with ground crews, and a white-glove service model designed around operator needs. Customers across onshore production, midstream, LNG, and offshore operations are increasingly re
Registrar Corp Acquires TechniCAL and Becomes the Global Compliance Leader in Shelf-stable Packaged Foods Safety4.2.2026 13:00:00 CET | Press release
Registrar Corp, the world’s largest food and beverage regulatory compliance provider, today announced its acquisition of TechniCAL, the world’s leading independent Process Authority for low-acid and acidified foods. Registrar Corp is a Paine Schwartz Partners portfolio company. Consumer demand for convenience and longer product life without refrigeration has driven rapid growth in shelf-stable foods and beverages, with packaging innovations extending beyond cans and glass jars to formats such as retort pouches and cartons. Ensuring products in these various packaging formats are safe from harmful microorganisms is critical to public health and required by the U.S. FDA. Together, Registrar Corp and TechniCAL provide the industry’s most complete solution, combining proven scientific expertise, regulatory knowledge, training, and advanced thermal testing. “TechniCAL is world renowned for its Process Authority expertise and advanced testing technologies assuring compliant thermal processin
Kinaxis Announces Intention to Maximize Size of Normal Course Issuer Bid4.2.2026 13:00:00 CET | Press release
Kinaxis® Inc. (“Kinaxis” or the “Company”) (TSX: KXS) today announces that it intends to amend its current normal course issuer bid (the “NCIB”) to increase the number of its common shares (the “Shares”) that may be repurchased from 1,403,042, representing 5% of the Company’s issued and outstanding Shares as at October 31, 2025, to approximately 2,799,843, representing 10% of the Company’s “public float” as at October 31, 2025, which is the maximum allowable under the rules of the Toronto Stock Exchange (the “TSX”). The Company has already invested US$54 million under its current NCIB. At the average price paid to date for the Shares under the current NCIB, repurchasing 10% of the Shares would represent an additional investment of approximately US$284 million. “There is a fundamental misunderstanding of the opportunities and threats from generative and agentic AI to mission-critical enterprise software, like ours, that solves deeply complex problems and enables highly consequential dec
Morgan Stanley Inclusive & Sustainable Ventures Hosts Global Demo Day, Opens Applications for Next Cohort4.2.2026 13:00:00 CET | Press release
Morgan Stanley (NYSE: MS) today is hosting its annual global Inclusive & Sustainable Ventures (MSISV) Demo Day, with startups and nonprofits participating from across the Americas, Europe, the Middle East and Africa (EMEA). The organizations will pitch over 300 investors, as well as potential business partners and customers. Over the past five months, MSISV has supported 29 startups and four nonprofits through an intensive accelerator program, providing them with capital, a tailored curriculum, mentorship opportunities and business-growth resources from Morgan Stanley’s ecosystem of internal and external partners. “With founders spanning 10 countries and 13 industries, our Morgan Stanley Inclusive & Sustainable Ventures cohort underscores the potential of innovators globally to bring disruptive solutions for business and society to market,” said Jessica Alsford, Morgan Stanley Chief Sustainability Officer. “We are eager to watch as these founders continue to scale with the backing of o
Macrobond Launches Macrobond Amplify, A New Standard for Interactive Financial Research4.2.2026 13:00:00 CET | Press release
Macrobond, the global platform for macroeconomic and financial data, announced the launch of Macrobond Amplify, a browser-based research distribution tool that enables economists and analysts to deliver rich, interactive content to their consumers at scale. Amplify empowers analysts and research teams to move beyond static charts and PDFs, delivering interactive, explorable insights that build trust, foster collaboration, and drive better decision-making. With Amplify, research teams can publish interactive, auditable research models that clients can explore directly through charts and dynamic visualizations. By sharing a simple link, Amplify users can distribute their research at scale with both internal partners and clients. “As the research industry evolves, analysts and economists face growing pressure to ensure their work reaches the right audiences, shows transparency, and demonstrates the rigour behind their thinking,” says Dan Seal, Chief Product Officer at Macrobond. “Amplify
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom